Clinical Trial Update: To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study [Phase 3]

View source ↗

Summary

A Phase 3, single-blind trial compared Terbutaline Turbuhaler with Salbutamol pMDI in asthma; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Salbutamol pMDI (salbutamol)
• Terbutaline Turbuhaler (terbutaline)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-08-31